Munich Cluster for Systems Neurology
print


Breadcrumb Navigation


Content

Mendelian randomization study of obesity and cerebrovascular disease.

Ann Neurol. 2020 Jan 24. doi: 10.1002/ana.25686. [Epub ahead of print]

Authors/Editors: Marini S, Merino J, Montgomery BE, Malik R, Sudlow CL, Dichgans M, Florez JC, Rosand J, Gill D, Anderson CD; International Stroke Genetics Consortium.
Publication Date: 2020

01_marini

Abstract

OBJECTIVE: To systematically investigate causal relationships between obesity and cerebrovascular disease, and the extent to which hypertension and hyperglycemia mediate the effect of obesity on cerebrovascular disease.

METHODS: We used summary statistics from genome-wide association studies for body mass index (BMI), waist-to-hip ratio (WHR) and multiple cerebrovascular disease phenotypes. We explored causal associations with two-sample Mendelian randomization (MR) accounting for genetic covariation between BMI and WHR; and assessed what proportion of the association between obesity and cerebrovascular disease was mediated by systolic blood pressure (SBP) and blood glucose levels respectively.

RESULTS: Genetic predisposition to higher BMI did not increase the risk of cerebrovascular disease. In contrast, for each 10% increase in WHR there was a 75% increase (95% confidence interval (CI)=44%-113%) in risk for large artery ischemic stroke, a 57% (CI=29%-91%) increase in risk for small vessel ischemic stroke, a 197% increase (CI=59%-457%) in risk of intracerebral hemorrhage, as well as an increase in white matter hyperintensity volume (β=0.11; CI=0.01-0.21). These WHR associations persisted after adjusting for genetic determinants of BMI. Approximately one tenth of the observed effect of WHR was mediated by SBP for ischemic stroke (12%; CI=4%-20%), but no evidence of mediation was found for average blood glucose.

INTERPRETATION: Abdominal adiposity may trigger causal pathological processes, partially independent from blood pressure and totally independent from glucose levels, that lead to cerebrovascular disease. Potential targets of these pathological processes could represent novel therapeutic opportunities for stroke. This article is protected by copyright. All rights reserved.

Related Links